Researchers launch large study to track HER2+ breast cancer survival

NCT ID NCT06603597

Recruiting now Knowledge-focused Sponsor: Priyanka Sharma Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This observational study will follow 1000 people with HER2-positive breast cancer to see how patient and tumor characteristics relate to outcomes like survival and treatment response. Participants are not given any new treatment—researchers simply collect data over time. The goal is to improve understanding of what influences long-term results in this type of breast cancer.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HER2 + BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast neoplasm HER2 positive breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HER2 + BREAST CANCER

Contacts and locations

Locations

KUCC - Briarcliff
ACTIVE_NOT_RECRUITING

Westwood, Kansas, 66205, United States
KUCC - Indian Creek
ACTIVE_NOT_RECRUITING

Overland Park, Kansas, 66211, United States
KUCC - Lee's Summit
ACTIVE_NOT_RECRUITING

Lee's Summit, Missouri, 64064, United States
KUCC - Olathe
ACTIVE_NOT_RECRUITING

Westwood, Kansas, 66205, United States
KUCC - Overland Park
ACTIVE_NOT_RECRUITING

Overland Park, Kansas, 66215, United States
The University of Kansas Cancer Center
RECRUITING

Westwood, Kansas, 66205, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.